The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia

• Status: Completed
• Trial end date: 2012-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective is to determine if there is a significant increase in the haematocrit value of patients on Jobelyn and standard therapy compared to those on standard therapy alone.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lagos State University
• Treatments: Folic Acid; Proguanil; Vitamin B Complex

Criteria

Inclusion Criteria:

• Male or female 14 to 45 years of age

• Haemoglobin SS

Exclusion Criteria:

• Patients with chronic inflammatory disease like tuberculosis

• Patients with chronic viral hepatitis or positive for human immunodeficiency virus

• Patients with autoimmune disorders.

. patients with other haemoglobinopathy

• Pregnancy or anticipated pregnancy.

• Patient on drug abuse or alcohol abuse.

• Patients on treatment for organ failure